Lavender Foal Syndrome
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
Condition snapshot
A concise guide to the condition’s pattern, detection, management and urgency.
Breeding advice appliesUse the screening guidance and veterinary or genetics advice before breeding an affected or at-risk animal.
Emergency presentation is possibleA newborn with severe extension, paddling, seizures or inability to sit sternally requires immediate neonatal assessment.
This snapshot is a general guide, not a diagnosis or treatment plan. New, severe or worsening signs require veterinary assessment.
About the condition
Lavender foal syndrome is a lethal inherited disorder of Arabian horses, particularly lines of Egyptian ancestry. A deletion in MYO5A disrupts transport functions important to pigment cells and neurons. Affected foals are usually born with an unusually dilute silver, pale pink or lavender-grey coat and severe neurological dysfunction present immediately at birth.
Typical signs include inability to stand or sit upright, rigid or paddling limbs, severe extension of the neck and back, seizures, involuntary eye movements and uncontrolled movement. The suck reflex may remain strong, which can misleadingly suggest that supportive feeding will lead to recovery. Difficult delivery is common, and signs may be mistaken for oxygen deprivation, spinal injury or neonatal maladjustment. The distinctive coat can be subtle when wet or viewed under artificial light, and colour alone must not replace testing.
The disorder is autosomal recessive. Clinically normal carriers pass the LFS variant to about half their offspring; two carriers have a one-in-four affected risk in each mating. The condition is not infectious, and carriers have no neurological disease from one copy.
Affected foals do not improve because the underlying neuronal defect cannot be corrected. Death or humane euthanasia occurs shortly after birth. Accurate recognition avoids prolonged intensive care and prevents recurrence. LFS must be separated from other treatable causes of neonatal weakness and seizures until genotype is known, but emergency support should not delay testing. Breeding prevention depends on validated DNA results for both parents rather than coat colour, pedigree assumptions or the absence of previously affected foals.
MYO5A dysfunction explains the linked pigment dilution and neurological phenotype, but coat shade varies with lighting and the foal's base colour. The rigid extended posture can make delivery difficult and can be mistaken for trauma from the dystocia it helped cause. Lack of improvement despite a strong suck separates the syndrome from many transient maladjustment cases.
Screening & Early Detection
A newborn with abnormal colour and severe extension, paddling, seizures or inability to assume sternal recumbency receives an immediate neonatal and neurological examination. The veterinarian checks oxygenation, glucose, temperature, trauma, infection, passive transfer and evidence of dystocia, because hypoxic-ischaemic encephalopathy and sepsis can coexist or mimic LFS.
A validated MYO5A DNA test on blood or properly identified hair roots confirms clear, carrier or affected genotype. Rapid laboratory communication is valuable when welfare decisions are urgent. Parentage is confirmed if a result is unexpected. Necropsy and retained DNA can resolve cases in which the foal dies before testing.
All Arabian breeding animals, especially those with Egyptian ancestry, are tested before pairing. A carrier looks completely normal, so visual screening cannot work. A negative result addresses the known LFS deletion but does not exclude other causes of neonatal neurological disease. Foaling history and photographs support the record, while clinical stabilisation continues until a defensible diagnosis is available.
The placenta and foaling record are reviewed for independent evidence of hypoxia or infection.
Treatment & Management
There is no curative treatment and affected foals do not acquire normal motor control. Short-term seizure control, oxygen, warmth, fluids and assisted feeding may be used while urgent diagnostic samples are processed, provided these measures do not prolong distress. A strong suck is not evidence of recovery. Once homozygous LFS is confirmed or the characteristic fatal syndrome is otherwise established, prompt humane euthanasia prevents ongoing seizures, injury and futile intensive care.
The mare is examined and treated for trauma or retained placenta after a difficult birth. The foal is handled on deep protected bedding to prevent head and limb injury during the brief assessment period. Samples and complete identification are preserved so the diagnosis informs the breeding programme.
Prevention is the effective management. Two carriers are never paired. Carrier-to-clear matings will not produce affected foals, though approximately half may be carriers and should be tested before breeding. Carriers themselves require no medication and can remain valuable when paired responsibly. Results are disclosed with breeding contracts and linked to permanent identity. Embryo testing may be considered in specialised programmes. Producing no prior affected foal does not prove a mating safe; every pregnancy between two carriers repeats the same 25% risk.
